US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Krystal Biotech, Inc. | $348.06 | 1.9% | $10.26B | 50.9 | 79.8% | — | Healthcare | 163.5% | 25.1% | ||
| 2 | Arcellx, Inc. | $115.07 | 0% | $6.73B | -28.3 | -102% | — | Healthcare | 80.3% | -79.4% | ||
| 3 | Legend Biotech Corporation | $27.93 | -16.7% | $5.17B | -17.5 | -15.2% | — | Healthcare | -19.9% | 56.4% | ||
| 4 | uniQure N.V. | $46.29 | -3.9% | $2.89B | -13.4 | 20% | — | Healthcare | 206.6% | -10.4% | ||
| 5 | Tevogen Bio Holdings Inc. | $9.71 | 0.1% | $1.92B | -103.7 | 47.6% | — | Healthcare | -83.8% | — | ||
| 6 | Sarepta Therapeutics, Inc. | $17.53 | 3.4% | $1.85B | -2.5 | 64.4% | — | Healthcare | -15.6% | -2.2% | ||
| 7 | Taysha Gene Therapies, Inc. | $6.42 | 3.7% | $1.84B | -18.9 | -7.3% | — | Healthcare | 149.8% | 3.4% | ||
| 8 | Precigen, Inc. | $4.82 | 1.9% | $1.45B | -3.4 | -127.1% | — | Healthcare | 223.5% | 652.1% | ||
| 9 | Iovance Biotherapeutics, Inc. | $3.91 | -0.5% | $1.4B | -3.6 | 25.8% | — | Healthcare | 91.7% | 34.3% | ||
| 10 | Immatics N.V. | $9.78 | 2.7% | $1.31B | -5.5 | -1040% | — | Healthcare | 67.2% | -74.1% | ||
| 11 | Capricor Therapeutics, Inc. | $28.38 | 1.5% | $1.3B | -12.6 | -63.4% | — | Healthcare | 137.7% | -100% | ||
| 12 | MeiraGTx Holdings plc | $11.32 | 8.7% | $1.05B | -8.0 | 36.2% | — | Healthcare | 74.7% | 131.1% | ||
| 13 | Sana Biotechnology, Inc. | $3.15 | 3.6% | $877M | -3.3 | -4.5% | — | Healthcare | 14.1% | — | ||
| 14 | Replimune Group, Inc. | $10.19 | 1.9% | $841M | -3.3 | -13.7% | — | Healthcare | 7.4% | — | ||
| 15 | Solid Biosciences Inc. | $8.33 | 14% | $649M | -4.2 | 30.1% | — | Healthcare | 79.1% | — | ||
| 16 | 4D Molecular Therapeutics, Inc. | $9.66 | 2.5% | $505M | -4.0 | 16.4% | — | Healthcare | 136.2% | 383560.9% | ||
| 17 | Neurogene Inc. | $31.53 | 2.4% | $498M | -7.4 | -7.7% | — | Healthcare | 72.3% | -100% | ||
| 18 | Allogene Therapeutics, Inc. | $2.00 | 2% | $488M | -2.3 | 37.4% | — | Healthcare | 55% | — | ||
| 19 | Cabaletta Bio, Inc. | $2.84 | 0% | $463M | -1.7 | 23% | — | Healthcare | 64.2% | — | ||
| 20 | Candel Therapeutics, Inc. | $8.31 | 4% | $456M | -11.5 | 20.7% | — | Healthcare | 68.9% | — | ||
| 21 | Ocugen, Inc. | $1.24 | 0.8% | $420M | -5.4 | -24.7% | — | Healthcare | 13.8% | -1.3% | ||
| 22 | REGENXBIO Inc. | $7.80 | -1.3% | $403M | -2.1 | -80.1% | — | Healthcare | -9% | -44% | ||
| 23 | Autolus Therapeutics plc | $1.51 | -1.3% | $402M | -1.4 | -22.5% | — | Healthcare | -26.7% | 927.5% | ||
| 24 | Lexeo Therapeutics, Inc. Common Stock | $4.93 | -1% | $387M | -2.7 | 56.1% | — | Healthcare | 16.3% | — | ||
| 25 | Rocket Pharmaceuticals, Inc. | $3.35 | 6% | $366M | -1.7 | 28.9% | — | Healthcare | 18.4% | — | ||
| 26 | Kyverna Therapeutics, Inc. | $8.07 | 0.4% | $353M | -2.2 | 2.7% | — | Healthcare | 177.3% | — | ||
| 27 | Abeona Therapeutics Inc. | $5.77 | 2.1% | $329M | 5.7 | 199.5% | — | Healthcare | -3.8% | — | ||
| 28 | Benitec Biopharma Inc. | $12.15 | 3% | $319M | -11.6 | 29.7% | — | Healthcare | -18.7% | — | ||
| 29 | Cellectis S.A. | $2.98 | -3.2% | $299M | -4.4 | -8.4% | — | Healthcare | 112.9% | 42.9% | ||
| 30 | Lyell Immunopharma, Inc. | $12.74 | 1.8% | $297M | -0.8 | -919.7% | — | Healthcare | 33% | -52.3% | ||
| 31 | ProKidney Corp. | $1.83 | 4.6% | $260M | -3.5 | 8.3% | — | Healthcare | 162.8% | 190.5% | ||
| 32 | Fate Therapeutics, Inc. | $2.09 | 6.6% | $244M | -1.8 | 26.8% | — | Healthcare | 72.7% | -52.6% | ||
| 33 | Artiva Biotherapeutics, Inc. | $9.82 | -1.2% | $243M | -2.9 | -11.3% | — | Healthcare | 484.5% | — | ||
| 34 | Voyager Therapeutics, Inc. | $3.72 | 2.8% | $225M | -1.8 | -35.6% | — | Healthcare | 22.4% | -45.5% | ||
| 35 | Nkarta, Inc. | $2.86 | 8.3% | $205M | -2.0 | 11.3% | — | Healthcare | 57.1% | — | ||
| 36 | Century Therapeutics, Inc. | $2.29 | 1.8% | $198M | -20.8 | -290.6% | — | Healthcare | 290.5% | -100% | ||
| 37 | Caribou Biosciences, Inc. | $1.64 | 0% | $163M | -1.0 | 12.3% | — | Healthcare | 28.1% | 13% | ||
| 38 | Protara Therapeutics, Inc. | $3.98 | -2.2% | $154M | -3.0 | 15.1% | — | Healthcare | 33.6% | — | ||
| 39 | Tenaya Therapeutics, Inc. | $0.73 | 2.7% | $122M | -1.2 | 59.5% | — | Healthcare | 26.3% | — | ||
| 40 | TScan Therapeutics, Inc. | $0.92 | 2.2% | $120M | -0.9 | 11.9% | — | Healthcare | -37% | 106.7% | ||
Showing 40 of 74 stocks